Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)
Johanna M W van den Berg1, Alison M Morton, Simon W Kok
1Adult Cystic Fibrosis Center, Department of Pulmonology, Haga Teaching Hospital, Leyweg 275, 2545 CH, The Hague, The Netherlands. j.m.w.vandenberg@hagaziekenhuis.nl
Insights
Cystic fibrosis-related diabetes (CFRD) patients show similar microvascular complications to type 1 diabetes (DM1) patients, but with differences in retinopathy and microalbuminuria. CFRD patients had lower BMI, cholesterol, and HbA1c levels.
Area of Science:
- Endocrinology
- Diabetology
- Pulmonology
Background:
- Cystic fibrosis-related diabetes (CFRD) presents unique challenges in managing microvascular complications.
- Comparison with type 1 diabetes mellitus (DM1) is crucial for understanding CFRD-specific risks.
Purpose of the Study:
- To quantitatively and qualitatively assess microvascular complications in CFRD versus DM1.
- To identify and compare risk factors associated with these complications.
Main Methods:
- Matched cohort study of 79 CFRD and 79 DM1 patients.
- Assessed retinopathy, peripheral neuropathy, nephropathy, and microalbuminuria.
- Evaluated risk factors including smoking, BMI, HbA1c, lipids, and blood pressure.
Main Results:
- Overall microvascular complication rates were similar (29%) between CFRD and DM1 groups.
- CFRD patients had significantly higher microalbuminuria (21% vs 4.1%) but lower retinopathy (10% vs 24%).
- CFRD patients exhibited lower BMI, total cholesterol, HbA1c, and smoking prevalence.
Conclusions:
- Microvascular complication profiles in CFRD are comparable to DM1, with distinct patterns in retinopathy and microalbuminuria.
- Increased microalbuminuria in CFRD may be linked to cystic fibrosis-specific factors impacting renal function.
Background:
This study aims to quantitatively and qualitatively assess microvascular complications and their risk factors in patients with cystic fibrosis-related diabetes (CFRD) compared to those with type 1 diabetes mellitus (DM1).
Methods:
79 patients with CFRD were matched with 79 patients with DM1 according to sex, age and duration of insulin therapy. Retinopathy, peripheral neuropathy, nephropathy and microalbuminuria were the microvascular complications assessed. Risk factors studied were: smoking, BMI, HbA1c, cholesterol, cholesterol/HDL ratio, diastolic and systolic blood pressure.
Results:
Both groups had the same number of microvascular complications (29%). CFRD patients showed more microalbuminuria (21% versus 4.1%; p=0.003), while retinopathy was more common in patients with DM1 (24% versus 10%; p=0.044). The prevalences of peripheral neuropathy and nephropathy were similar. Patients with CFRD had lower BMI (p<0.0001), total cholesterol (p<0.0001) and HbA1c (p=0.056) levels, and a lower prevalence of smokers (p<0.0001). Cholesterol/HDL ratio and diastolic and systolic blood pressure were similar in both groups.
Conclusions:
The microvascular complications shown by patients with CFRD are similar to those seen in patients with DM1 but with a lower prevalence of retinopathy and a higher prevalence of microalbuminuria. The latter may reflect the influence of other cystic fibrosis-related factors on renal function.
More Related Videos
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
Published on: December 26, 2017
08:10An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Related Concept Videos
Diabetic Retinopathy
Complications of Diabetes Mellitus
Diabetic Foot Ulcer
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Diabetic Nephropathy
